TY - JOUR
T1 - Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual
T2 - Procoagulant vitamin K-dependent clotting factors
AU - Zivelin, Ariella
AU - Vijaya Mohan Rao, L.
AU - Rapaport, Samuel I.
PY - 1993
Y1 - 1993
N2 - We have evaluated the contribution of depression of individual procoagulant vitamin K-dependent clotting factors to the ability of warfarin to protect rabbits against tissue factor-induced coagulation. Mean activities of individual procoagulant factors were determined, in assays with rabbit substrates, for a group of rabbits achieving a protective degree of anticoagulation with warfarin. Values were: factor VII, 12%; factor IX, 7%; factor X, 14%, and prothrombin, 13%. The effect upon tissue factor-induced coagulation of selective immunodepletion of each factor to a comparable level was then evaluated. Immunodepletion of plasma factor X or prothrombin, but not of factor VII or factor IX, protected otherwise normal rabbits against tissue factor-induced coagulation. Next, we determined the effect upon the protection in warfarin-treated rabbits of selectively restoring factor X or prothrombin before infusing tissue factor. When either factor was selectively restored, warfarin's protective effect was abolished. Moreover, selective restoration of prothrombin sensitized warfarin-treated rabbits to coagulation more severe than observed in nontreated control rabbits. One may extrapolate from these data that depression of both factor X and prothrombin are required for warfarin's clinical antithrombotic efficacy and that depression of plasma prothrombin is particularly important.
AB - We have evaluated the contribution of depression of individual procoagulant vitamin K-dependent clotting factors to the ability of warfarin to protect rabbits against tissue factor-induced coagulation. Mean activities of individual procoagulant factors were determined, in assays with rabbit substrates, for a group of rabbits achieving a protective degree of anticoagulation with warfarin. Values were: factor VII, 12%; factor IX, 7%; factor X, 14%, and prothrombin, 13%. The effect upon tissue factor-induced coagulation of selective immunodepletion of each factor to a comparable level was then evaluated. Immunodepletion of plasma factor X or prothrombin, but not of factor VII or factor IX, protected otherwise normal rabbits against tissue factor-induced coagulation. Next, we determined the effect upon the protection in warfarin-treated rabbits of selectively restoring factor X or prothrombin before infusing tissue factor. When either factor was selectively restored, warfarin's protective effect was abolished. Moreover, selective restoration of prothrombin sensitized warfarin-treated rabbits to coagulation more severe than observed in nontreated control rabbits. One may extrapolate from these data that depression of both factor X and prothrombin are required for warfarin's clinical antithrombotic efficacy and that depression of plasma prothrombin is particularly important.
KW - Factor VII
KW - Factor X
KW - Intravascular coagulation
KW - Prothrombin
KW - Tissue factor
UR - http://www.scopus.com/inward/record.url?scp=0027520694&partnerID=8YFLogxK
U2 - 10.1172/JCI116814
DO - 10.1172/JCI116814
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8227329
AN - SCOPUS:0027520694
SN - 0021-9738
VL - 92
SP - 2131
EP - 2140
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 5
ER -